Sheri Lenee Albers, DO, is a highly distinguished radiologist and interventional pain physician with over three decades of leadership in diagnostic imaging and regenerative medicine. Currently serving as the Director of Research for Radiology Research and Consultation, Dr. Albers has held prestigious academic appointments, including Associate Professor and Section Chief of Musculoskeletal and Body MRI at the University of Kentucky. Her extensive expertise is supported by fellowships in Interventional Pain Medicine from UC San Diego and Neuroradiology from UC Davis. She served as the President of the American Society of Interventional Pain Physicians (ASIPP) from 2022 to 2023. A prolific researcher and educator, she was recognized with the ASIPP Lifetime Achievement Award in 2025.

WIRM Advisory Board Member Pradeep Albert, MD, is a pioneering diagnostic radiologist and healthcare innovator with over two decades of clinical experience. As a global leader in regenerative medicine and musculoskeletal imaging, he founded RadSherpa to develop AI solutions for medical imaging and leads PURE Mammography to improve diagnostic access. Dr. Albert currently serves as Chairman and Chief Longevity Officer of Dorado Health and President of the Center for Regenerative Medicine in Antigua. He authored the definitive 2023 textbook, Exosomes, PRP, and Stem Cells in Musculoskeletal Medicine, and has performed over 40,000 regenerative procedures. He is also a key architect of biotechnology policy, drafting regenerative medicine legislation across the Caribbean and Europe.

WIRM Advisory Board Member Chair of the WIRM Indonesia Chapter Ahmad Muttaqin Alim, MD, is a physician specializing in interventional pain medicine and regenerative therapy with particular expertise in minimally invasive procedures such as needle nanoscopy. He leads a clinical practice focused on biologically driven strategies for managing chronic spine and musculoskeletal disorders to restore function and support tissue healing. As Chair of the WIRM Indonesia Chapter, he advances education, research collaboration, and the responsible clinical translation of regenerative medicine. Additionally, Dr. Alim serves as a lecturer at a Faculty of Medicine and is a member of the expert team at a stem cell research laboratory. He is a dedicated author focused on the advancement of regenerative pain medicine.

WIRM Advisory Board Member Mary A. Ambach, MD, holds double board certifications in Physical Medicine & Rehabilitation and Pain Medicine, with dual fellowship training in Orthopedic Sports & Spine and Orthobiologic & Regenerative Medicine. She is a Clinical Instructor and Voluntary Assistant Clinical Professor at the University of California San Diego School of Medicine. As the founder of Bioevolve and the San Diego Orthobiologics and Sports Center, she provides advanced orthopedic regenerative treatments backed by two decades of clinical experience. Dr. Ambach is a global mentor on autologous cell therapies and serves on several regenerative boards. She is the President-Elect for the Interventional Orthobiologics Foundation (IOF).

WIRM Advisory Board Member Shahzad Anwar, MD, is a renowned international authority and a pioneer in Regenerative and Interventional Pain Medicine in Pakistan, with over 30 years of clinical experience. He is widely respected for establishing evidence-based, non-surgical pain management services and has trained hundreds of physicians across Asia, Europe, and the Middle East in image-guided interventions. Dr. Anwar specializes in complex spine pain, advanced regenerative injections, and autologous stem cell therapy. As a visionary leader, he directs the strategic expansion of pain and regenerative services globally, ensuring international standards of innovation. His educational initiatives have been pivotal in standardizing pain medicine as a recognized subspecialty in his region.

Ripu Arora, MD, MBA, is a board-certified pain management anesthesiologist and the founder of Arora Pain Clinic in Torrance, California. His practice emphasizes Interventional Pain Management and Regenerative Medicine, utilizing a multidisciplinary approach to address physical and socio-psychological patient needs. Dr. Arora completed orthopedic and surgical training in India and England before undergoing residency in anesthesiology at Case Western University. He also holds an MBA in healthcare from the University of California, Irvine. Dr. Arora serves on the board of the California Society of Interventional Pain Physicians (CalSIPP) and is a life member of ASIPP. He is also a dedicated board member for the Illumination Foundation.

WIRM Advisory Board Member Gabriel Azzini, MD, is a specialist in orthopedics, sports medicine, and regenerative treatments with medical degrees from Brazil, Portugal, and England. He holds a Fellowship in Regenerative Medicine from Oasi Bioresearch in Milan and serves as a postgraduate professor at OrthoRegen and the Max Planck University Centre. As a researcher at the Brazilian Institute of Regenerative Medicine, Dr. Azzini has contributed to dozens of scientific publications. He is recognized as a leading reference in innovative medical treatments, reaching a wide audience through his YouTube channel, which has over 2 million subscribers. His work focuses on transforming lives through evidence-based, biological approaches to orthopedic recovery.

WIRM Vice Chair Dr. Douglas P. Beall, is board-certified in Diagnostic Radiology, has an added fellowship in Musculoskeletal Radiology, is a Diplomate of the American Academy of Pain Management and is a Fellow of the Society of Interventional Radiology, the American Society of Interventional Pain Physicians and a Fellow of Interventional Pain Practice and board certified by the World Institute of Pain. He is currently in private practice focused on interventional pain management and minimally invasive surgical procedures.

Marshall Bedder, MD, is the Chief Medical Officer for Neuralace Medical and an Associate Professor at the Medical College of Georgia. Triple board-certified in Anesthesia, Pain Medicine, and Addiction Medicine, he is a world authority on magnetic peripheral nerve stimulation (mPNS) for neuropathic pain. Dr. Bedder founded the Pain Medicine Service at the VA Augusta Health System and established the Addiction Medicine Fellowship at MCG. He is a past President-Elect of the North American Neuromodulation Society (NANS) and a Board Member Emeritus for the American Society of Pain and Neuroscience (ASPN). With over 50 publications, he continues to lead global workshops on implantable therapies that have become industry standards.

David Bell is the Founder and CEO of BORN and serves as a Clinical Regenerative Science Advisor at Elite CellFusion. He holds a BS in Chemistry and a BA in Anatomy & Physiology from Florida State University. With over 25 years of experience across the health, laboratory, and biotechnology sectors, he has been at the forefront of innovation in regenerative science. He co-founded Wellness Rx in 2017 and led the development of the first legal shelf-stable regenerative product in the United States. His work has significantly advanced affordability and scalability, increasing yields, reducing R&D costs, and accelerating time to commercialization.

Sigurd H. Berven, MD, is a specialist in spinal disorders, with clinical interests ranging from pediatric deformity and degenerative conditions to spinal tumors and trauma. He is a graduate of the Harvard Combined Orthopedic Residency and earned his medical degree from Harvard Medical School. Dr. Berven’s research focuses on assessment of clinical outcomes, minimally invasive techniques, and biological regeneration of the intervertebral disc. He has served as a clinical fellow at UCSF and as chief resident at Boston Children’s Hospital. An invited speaker at major international conferences, he is recognized for his work in evaluating advanced spine surgery techniques. He also studied philosophy, politics, and economics at Oxford University.

Sumrita Bhat, PhD, is the Founder and CEO of Conlis Global Inc., a Canadian MedTech company dedicated to translating biomaterials and regenerative technologies into clinical solutions. With a doctorate in bioengineering and a strong background in tissue engineering, she leads the development of innovative orthopedic technologies, most notably NanoCement™, a next-generation bone repair material. Dr. Bhat operates at the intersection of academia and industry, fostering global collaborations to accelerate the movement of research toward patient-centric medical devices. Her work emphasizes scalable solutions and biomaterials innovation aimed at improving surgical outcomes and expanding access to advanced healthcare technologies worldwide. She remains committed to advancing the field of tissue engineering through strategic commercialization.

Navneet Boddu, MD, is a regenerative medicine specialist based in San Diego, California, and the founder of Advanced Pain and Regenerative Specialists. He utilizes autologous bone marrow, adipose stem cells, and platelet-rich plasma (PRP) to treat musculoskeletal disorders of the spine and joints. Dr. Boddu has been voted a “Top Doctor” in Pain Medicine and Anesthesiology six times in San Diego County and received the 2025 Manchikanti Award of Excellence in Regenerative Medicine. He is one of the few U.S. physicians to conduct FDA-authorized umbilical cord mesenchymal stem cell treatments for critically ill COVID-19 patients. Dr. Boddu is a published author of numerous journal articles and textbook chapters.

WIRM Advisory Board Member Peter Boyd, JD, MBA, is a healthcare entrepreneur with a multifaceted background in business, science, and law. As a co-founding member of Harpoon Medical, he successfully managed all aspects of its complex financing and subsequent nine-figure acquisition by Edwards Lifesciences. Mr. Boyd’s early career in the life sciences began at Vapotherm, Inc., and he previously practiced law as an associate at Latham & Watkins in Silicon Valley. He is a named inventor on seven patents, reflecting his deep involvement in technical innovation. Mr. Boyd holds a JD/MBA from the University of Virginia. He leverages his legal and operational expertise to guide medical startups through the rigorous process of funding and commercialization.

WIRM Advisory Board Member Roger Brown has served as the Musculoskeletal Therapeutic Area Head at Mesoblast since 2009, where he oversees the development of biological products for musculoskeletal conditions. He possesses over 30 years of extensive experience in clinical affairs, regulatory strategy, and product development for technologies ranging from physiological monitors to implantable biologics. Prior to his role at Mesoblast, Mr. Brown was the Divisional Vice President of Clinical, Regulatory, and Quality for Abbott Laboratories’ Spine Division. His career includes significant clinical and regulatory roles at organizations such as Axiomed Spine Corporation, Wright Medical Technology, and CryoLife. He is an expert in navigating the complex reimbursement landscapes required to bring advanced medical technologies to market.

Ryan Budwany, MD, is a board-certified physician specializing in interventional pain and functional medicine. He holds a medical degree from Mercer University and multiple advanced degrees, including an MBA and an MPH focused on patient safety. Dr. Budwany has served as the Young Physicians Section Chair for the West Virginia State Medical Association, advocating for improved patient access to integrative care. He is also the Executive Director of Medical Diplomats International, a nonprofit dedicated to improving rural healthcare outcomes. Notably, he collaborated with NASA on research regarding microgravity’s effects on the spine. Dr. Budwany focuses on minimally invasive procedures and regenerative medicine to repair injuries and optimize patient functional quality of life.

WIRM Advisory Board Member Don Buford, MD, is a board-certified orthopedic surgeon specializing in sports medicine and regenerative orthopedics. Based in Dallas, Texas, he founded Texas Orthobiologics, a concierge practice focused on advanced treatments such as bone marrow-derived therapies and platelet-rich plasma. With over 20 years of experience, Dr. Buford is a national and international lecturer on regenerative medicine. He currently serves as the President of the Interventional Orthobiologics Foundation (IOF) and is a founding editor of the Biologic Orthopedics Journal. In recognition of his significant contributions to the field, he was honored with the 2025 Lifetime Achievement Award from TOBI (The Orthobiologic Institute). He remains a leader in advancing evidence-based orthopedic standards.

Joseph A. Cabaret, MD, is a triple board-certified physician in Pain Medicine, Addiction Medicine, and Anesthesiology based in Camarillo, California. With over 26 years of experience, he focuses on interventional pain management, regenerative medicine, and addiction care, striving to heal the root causes of pain. A graduate of the University of Bologna School of Medicine in Italy, he completed his residency at the University of Southern California. Beyond clinical practice, Dr. Cabaret is dedicated to humanitarian work, providing medical care and education to orphans and widows in Kenya through Tumaini International. He is passionate about empowering patients to reclaim their lives through personalized, evidence-based care and root-cause healing.

WIRM Advisory Board Member Aaron Kenneth Calodney, MD, is a past President of the American Society of Interventional Pain Physicians (ASIPP) and the Texas Pain Society. Board-certified in Anesthesiology with subspecialty certification in Pain Management, he serves on the Advisory Board for the World Institute of Pain (WIP). Dr. Calodney is a Master Instructor for the International Spine Intervention Society (ISIS) and has delivered over 250 invited lectures. His research focuses on neuromodulation, biological treatments for degenerative discs, and radiofrequency ablation. He authored the first evidence-based treatment guidelines for interventional pain and opioids. Dr. Calodney earned his MD from the University of Missouri and completed his fellowship at the University of Texas Health Science Center at Houston.

Harvey Castro, MD, MBA, known as “DrGPT,” is an emergency medicine physician, AI futurist, and healthcare executive. With over 20 years of clinical experience, he focuses on the responsible integration of artificial intelligence into patient care and clinician workflows. Currently, he serves as Chief AI Officer at Phantom Space Corporation and advises global organizations on AI strategy, governance, and ethical deployment. A five-time TEDx speaker and author of ChatGPT & Healthcare (2022), Dr. Castro is internationally recognized for translating complex technological concepts into practical medical applications. He bridges the gap between real-world medicine and emerging technology to improve health system performance and patient safety. He remains a prominent voice in human-centered healthcare innovation.

Uli K. Chettipally, MD, is an award-winning physician, researcher, and entrepreneur with over 20 years of experience in emergency medicine and digital therapeutics. He is the founder of Sirica Therapeutics, a startup developing a robotic and virtual reality system to make therapy fun and effective for children with autism. Additionally, Dr. Chettipally is the founder and President of InnovatorMD, a global platform dedicated to physician innovation. He has authored several books, including Punish The Machine—The Promise of Artificial Intelligence in Healthcare. Dr. Chettipally also runs a Health Tech accelerator in partnership with the Founder Institute and is passionate about leveraging technology to improve healthcare affordability and outcomes.

WIRM Advisory Board Member Timothy T. Davis, MD, is an interventional pain management specialist with over 20 years of experience in physical medicine, sports medicine, and pain management. Board-certified in PM&R, pain medicine, and neurophysiological monitoring, he is the founder of Source Healthcare. Dr. Davis is a prolific researcher and has served as the principal investigator for numerous clinical trials exploring stem cell treatments for arthritis and degenerative disc disease. He holds patents in biologics, spinal implants, and electrodiagnostics. Dr. Davis serves on the medical staff at Cedars-Sinai Medical Center and Providence Saint John’s Health Center. He earned his medical degree from the University of Missouri-Kansas City in a combined six-year program.

Mark de Souza, PhD, is the CEO of SonALAsense, Inc., where he leads the development of non-invasive sonodynamic therapy for rare cancers. With over 25 years of executive experience in the rare disease sector, he has founded or led numerous venture-backed companies, including Lotus Tissue Repair, SeylanMed, and Kamal Therapeutics. Previously, he served as Vice President of Business Development at Dyax Corp, contributing to the development of FDA-approved drugs for hereditary angioedema. Dr. de Souza is a dedicated advocate for the rare disease community, serving as an advisor to the CureGM1 Foundation and a board member of SNAPkids. He leverages his deep entrepreneurial background to drive clinical innovation from early-stage research to patient-ready therapies.

WIRM Advisory Board Member Ariana DeMers, DO, is a fellowship-trained orthopedic sports medicine surgeon and a leading expert in regenerative medicine. She is the founder and CEO of the Joint Vitality Institute at Restore Orthopedics and Sports Medicine, where she has pioneered a patient-centered care model. Her approach uniquely blends orthobiologic precision with hormonal optimization and lifestyle medicine to help patients avoid unnecessary surgery and age vibrantly. Dr. DeMers is dedicated to redefining the delivery of musculoskeletal and longevity care. Through her leadership, she continues to advance the clinical application of regenerative therapies within a comprehensive framework of wellness and functional recovery.

WIRM Advisory Board Member Didier Demesmin, MD, MBA, is a double board-certified physician in Interventional Pain Medicine and Anesthesiology with over 20 years of clinical experience. He serves as the CEO and Medical Director of University Pain and Spine Center, leading a team providing advanced, minimally invasive treatments. Dr. Demesmin is the Director of Pain Medicine at Saint Peter’s University Hospital and an Associate Program Director at the JFK Johnson Rehabilitation Institute. Additionally, he is a faculty member at Rutgers RWJ Medical School. An active researcher and lecturer, he has authored multiple textbook chapters on pain procedures. His work is focused on delivering tailored, evidence-based care to patients suffering from complex spine and pain disorders.

Dr. Rahul N. Desai is Chief Medical Advisor and Co-Visionary at RedVive Health, where he advances the integration of evidence-based photobiomodulation into mainstream medicine. He leads efforts to deliver clinically validated red and near-infrared light therapies that support recovery, pain management, performance, and systemic healing, while equipping providers with protocols, education, and scalable practice models.

With over a decade as Founder and CEO of RestorePDX, he specialized in regenerative musculoskeletal and interventional radiology. He has served as Adjunct Assistant Professor at Stanford University School of Medicine and completed fellowship training at Washington University in St. Louis. His work focuses on expanding access to minimally invasive, evidence-based therapies.

WIRM Vice Chair Dr. Sudhir Diwan is a nationally and internationally recognized leader in pain management. He is President of Park Avenue Spine and Pain in New York and Associate Clinical Professor at Albert Einstein College of Medicine. Formerly Director of Pain Medicine at Weill Cornell, he has published extensively and co-edited several major textbooks. Dr. Diwan serves on editorial boards of leading journals, is an examiner for ABIPP and FIPP, and lectures globally. He is Executive Director of NYSIPP and Chair of the NYNJ Pain Medicine Congress, and a past President of the American Society of Interventional Pain Physicians (ASIPP).

WIRM Advisory Board Member Jeff Donner, MD, is a dual board-certified orthopedic and spinal surgeon with 35 years of clinical experience. Over the past decade, he has transitioned his focus toward natural healing techniques, specializing in bone marrow-derived orthobiologics. This clinical interest led him to identify and develop BMAX, a unique micronized bone marrow product. Dr. Donner’s research demonstrates that this product offers superior pain relief and regenerative properties compared to traditional BMC in both preclinical and clinical settings. His work aims to improve the regenerative capacity of bone marrow to achieve both disease-modifying and analgesic effects. He remains dedicated to advancing natural interventions for degenerative conditions of the entire spine.

WIRM Advisory Board Member Peter A. Everts, PhD, is the Senior Director of Medical Affairs at Bioventus LLC and an Adjunct Professor at the University of Queensland Medicine School. He also serves as a Professor at the Max Planck University Center in Brazil. With a doctorate from the University of Utrecht, Dr. Everts is a highly skilled Chief Scientific Officer with extensive experience in the medical practice industry. His expertise lies in biological therapies for orthobiologics, spine, chronic wound care, and regenerative medicine applications, including hair regrowth and facial aesthetics. He has a demonstrated history of translating complex scientific principles into effective clinical practices. Dr. Everts remains a leading voice in global biological medicine and orthopedic research.

Robin Farmanfarmaian is a professional speaker and healthcare technology expert who has delivered more than 250 keynotes across 16 countries. She specializes in making complex medical technologies understandable and actionable for stakeholders ranging from patients to policymakers. Robin has worked with major healthcare leaders, including the White House, Stanford Hospital, UnitedHealthcare, and Roche. She serves on the advisory boards of numerous innovative companies, such as iSono Health (AI ultrasound), CompanionIQ (post-surgical AI companion), and Luxsonic (VR for radiology). Additionally, she is involved in cutting-edge longevity through VitaKavana and senior care investments via Woodlawn Health Ventures. Her mission is to empower the healthcare ecosystem through technological adoption.

WIRM Advisory Board Member Sina Farzaneh, PhD, is the Scientific Director at EmCyte Corporation, where he leads innovation in advanced autologous biologics harvesting systems, such as BMAC and PRP. With nearly 20 years of experience in tissue engineering, biomaterials, and cellular therapy, he focuses on translating scientific research into practical solutions for musculoskeletal, aesthetic, and wound care. Dr. Farzaneh is an accomplished researcher with 12+ peer-reviewed publications and serves as a reviewer for several prominent scientific journals. An international speaker, he is recognized for integrating engineering principles with evidence-based therapies to support performance-focused care and longevity. His work continues to bridge the gap between complex laboratory science and clinical application in regenerative medicine.

WIRM Advisory Board Member Leonardo Henrique Cunha Ferraro, MD, is an Associate Professor at the Federal University of São Paulo and a physician specializing in interventional pain medicine. He holds the Certified Interventional Pain Sonographer (CIPS) credential, signifying advanced expertise in ultrasound-guided procedures and precision-based care. Dr. Ferraro’s clinical focus is on comprehensive pain management strategies that integrate minimally invasive techniques with multidisciplinary collaboration. He is actively involved in the international pain community, contributing to both clinical practice and the education of future specialists. His commitment to innovation and continuous professional development ensures that his patients receive evidence-informed care. He remains dedicated to improving patient outcomes through the advancement of pain medicine.

Aaron Fields, PhD, is a Professor of Orthopedic Surgery at UCSF and director of the Orthopedic Biomechanics and Biotransport Laboratory. He earned his doctorate in Mechanical Engineering from UC Berkeley, where his research focused on vertebral fragility using high-resolution computational models. Dr. Fields’ current research explores structure-function relationships in musculoskeletal tissues, specifically nutrient transport mechanisms in bone and cartilage. His lab combines biology and engineering to develop translatable diagnostic and therapeutic strategies for tissue repair and regeneration. An active member of the Orthopedic Research Society, he has published extensively on how tissue constituents at the nano- and microscales impact whole-organ behavior. His work is vital for understanding the effects of aging on musculoskeletal health.

WIRM Advisory Board Member Timothy Ganey, PhD, is the Chief Technology Officer for VIVEX Biologics and previously served as the Director of Orthopedic Research at Atlanta Medical Center. As the former President of Co.don Tissue Engineering, he led the development of the first clinically available biologic for treating intervertebral discs in 1999. Dr. Ganey has been a key figure in several technology initiatives, including additive manufacturing (3D printing), cell-based therapeutics, and electric field transduction. His professional mission is aligned with the shifting paradigm toward regenerative treatments for effective patient care, viewing translation as the primary engine for medical implementation. He remains a leader in advancing prescribed matrices and innovative therapeutic solutions for the global regenerative medicine community.

Dr. Michael C. Gerling is a board-certified orthopedic spine surgeon and Director of Musculoskeletal Care at Bayonne University Hospital in New Jersey. He specializes in minimally invasive and endoscopic spine surgery, and regenerative medicine, focusing on degenerative and traumatic spinal conditions. Dr. Gerling has held numerous leadership roles and served on national and international committees, including the Cervical Spine Research Society, where he was Chairman of Education. He has contributed extensively to peer-reviewed research and is committed to advancing spine care through innovation, education, and improved patient outcomes.

WIRM Advisory Board Member Lisbeth Godinez Ortiz, MD, is the leader of the Guatemala Pain Institute (GPI) and a prominent member of the pain management team at the Instituto Guatemalteco de Seguridad Social. Originally from Guatemala, she specialized in anesthesiology before completing a residency in Pain Management and Palliative Care in Mexico. Dr. Godinez was recognized as the Overall Winner Trainee at the ASIPP 25th Annual Meeting in 2023 for her research contributions. She is an active member of the Society of Women Innovators in Pain Medicine (WIPM), advocating for the role of Latin women in the field. Her mission is focused on enhancing patient care and expanding the availability of specialized pain management in her home country.

Mayank Gupta, MD, is a board-certified interventional pain management physician and the President and CEO of Kansas Pain Management. He specializes in minimally invasive spine care, neuromodulation, and advanced techniques such as spinal cord and peripheral nerve stimulation. Dr. Gupta serves as President of the Kansas Society of Interventional Pain Physicians (KSIPP) and is a Director-at-Large for the American Society of Interventional Pain Physicians (ASIPP). He is an adjunct clinical assistant professor at Kansas City University and a frequent speaker at national conferences like NANS and ASPN. His mission is to provide personalized care that prioritizes functional improvement and long-term relief while reducing patient reliance on medication.

Karolynn Halpert Correa, MD, is the Chief Medical Officer at BioXcellerator and a specialist in Emergency Medicine and Health Administration. She earned her medical degree from Universidad CES and holds a Master’s in Health Administration, reflecting her dual expertise in clinical excellence and healthcare management. As a leading researcher within the BioXscience Advanced Therapies and Translational Medicine group, Dr. Halpert focuses on biotechnology innovation and the clinical application of mesenchymal stem cell therapies for conditions such as rheumatoid arthritis and COVID-19 sequelae. She is an active member of the American Society of Gene & Stem Cell Therapy and the American Academy of Regenerative Medicine. An accomplished international speaker and educator, she is dedicated to advancing global standards in regenerative medicine and patient care through evidence-based research.

WIRM Advisory Board Member Sealy Hambright, PhD, earned his doctorate in neurobiology from the Barshop Institute for Longevity and Aging Studies at UTHealth San Antonio. He previously served as the Principal Investigator and Program Director for Healthy Aging Diagnostics at the Steadman Philippon Research Institute. His research focuses on stem cell biology and the use of senolytic drugs to improve functional orthopedic outcomes related to aging and senescence. Dr. Hambright is the Principal Consultant for Hambright Consulting LLC and holds research positions with Boston Children’s Hospital and BMAX Medical. Additionally, he is a co-founder of several startups, including TriCelX and Frame Longevity. He remains dedicated to advancing interventions that improve orthobiologic efficacy in aging populations.

Johnny Huard, PhD, is a world-renowned scientist and the Chief Scientific Officer and Director of the Center for Regenerative Sports Medicine at the Steadman Philippon Research Institute (SPRI). Dr. Huard is an expert in gene therapy, tissue engineering, and regenerative medicine using adult derived stem/progenitor cells.  He has published over 500 peer reviewed papers, over 100 reviews/book chapters, and over 1000 abstracts have been accepted for presentations at national and international conferences (Citations 54326; h-index:122, i10-index:428). His research team has received numerous awards including the 2026 Arnold I. Caplan Award for work on the origin, mechanism of action(s), and clinical application of MSCs. They are currently conducting multiple clinical trials in orthobiologics for musculoskeletal disease and conditions.

Brad Jacobs, MD, is a leader in integrative and lifestyle medicine, board-certified in both Internal and Integrative Medicine. He is a Diplomate of the American Board of Integrative and Holistic Medicine and holds a medical degree from Stanford University. Dr. Jacobs also earned a Master’s of Public Health from UC Berkeley, specializing in Epidemiology and Biostatistics. His unique clinical approach combines conventional medicine with genomic, lifestyle, and alternative practices to optimize patient health. An experienced educator and healthcare innovator, he focuses on corporate health and holistic wellness. He remains dedicated to bridging the gap between traditional medical standards and emerging integrative therapies to provide comprehensive, individualized patient care.

Reena Jadhav is a technology entrepreneur, investor, and global advocate for whole human health. With over 25 years in technology, she holds an MBA from Harvard and a BSc from Wharton. Reena is the founder of Wishing Well Inc., a nonprofit overseeing platforms like FreeMeals.org and HealCircle.org, an AI-powered longevity platform. She chairs the Compensation & Workforce Committee for Stanford Health Care Tri-Valley and hosts the “Healthier with Reena” podcast. After surviving major health crises, she dedicated her career to helping others discover pathways to resilience and healing. Her mission is to empower individuals to prevent disease and unlock human potential through integrative, science-backed solutions.

WIRM Advisory Board Member Chair of the WIRM India Chapter Neeraj Jain, MD, is a Senior Consultant Interventional Spine and Pain Specialist based in New Delhi. He specializes in non-surgical, image-guided procedures for complex conditions such as disc herniation, cancer pain, and trigeminal neuralgia. Dr. Jain is a pioneer in advanced interventional techniques and holds the CIPS and FIPP credentials. He is the innovator of several medical procedures, including the NJ Balloon Epiduro-Neuroplasty and NJ Disc Endoscopic Disc-Meshplasty. As Chair of the WIRM India Chapter, he is a dedicated mentor who regularly conducts workshops to train upcoming specialists. With over 240 international presentations and a YouTube channel with 1.4 million views, he is a global authority in pain medicine.

WIRM Advisory Board member Henry Ji, PhD, is the Executive Chairman, CEO, and President of Semnur Pharmaceuticals and Scilex Holding Company. With over 25 years of experience in biotechnology, he also co-founded Sorrento Therapeutics, serving as Chairman and CEO. During his tenure at Sorrento, Dr. Ji led significant acquisitions, including Scilex and Virttu Biologics. Previously, he held executive roles at CombiMatrix and Stratagene, where he founded Stratagene Genomics. Dr. Ji earned his doctorate from the University of Minnesota and an undergraduate degree from Fudan University. He is recognized for his leadership in engineering biotechnology growth and his deep expertise in life sciences innovation and executive management.

WIRM Advisory Board Member Manish Khanna, MD, is a prominent orthopedic surgeon and the founder of the Indian Orthopedic Rheumatology Association (IORA). He serves as the chairperson of the Indian Stem Cell Study Group and is the former Secretary and Vice President of the Indian Foot & Ankle Society. Dr. Khanna was previously a Senior Consultant at the Sanjay Gandhi Postgraduate Institute of Medical Sciences. His expertise focuses on ankle and foot surgeries, lower limb deformity correction, and orthopedic rheumatology. For the past five years, he has concentrated on stem cell therapy for neurological and orthopedic conditions and has led multiple clinical studies. He currently serves as the Chief Consultant at the Apley Orthopedic Centre in Lucknow.

Dobri Kiprov, MD, is a Harvard-trained immunologist and an internationally recognized pioneer in apheresis with over 100 publications. A founding member of the American Society of Apheresis (ASFA), he has served on its Board of Directors and as Chairman of the Division of Immunotherapy at California Pacific Medical Center. Dr. Kiprov founded Global Apheresis to research human aging and pioneered the use of Therapeutic Plasma Exchange (TPE) in longevity, holding a patent for its application in ameliorating aging effects. He is a senior visiting scientist at the Buck Institute for Research on Aging. Previously, he served as Medical Director for Apheresis at Fresenius Medical Care for 15 years.

WIRM Advisory Board Member Chair of the WIRM Italian Chapter Giuliano Lo Bianco, MD, PhD, FIPP, EDPM, is an Italian anesthesiologist and interventional pain specialist renowned for fluoroscopy and ultrasound guided percutaneous procedures and neuromodulation. Since 2020 he has directed the Analgesia & Percutaneous Surgery Unit at Fondazione G. Giglio, Cefalù, uniting high volume clinical practice with translational pain research. He earned a PhD in Neuroscience from the University of Catania, fellowship in Neuromodulation and Pain Medicine. Certified FIPP and EDPM in 2022, Dr Lo Bianco lectures on pain therapy at the Universities of Palermo and Pavia, organizes the Mediterranean Pain Forum, and serves as Section Editor for Pain Education and Early Career Investigators in the Journal of Pain Research.

WIRM Advisory Board Member Anthony Lowman, PhD, is the Provost and former Dean of Engineering at Rowan University. He also serves as the CTO and Co-Founder of ReGelTech. His research focuses on the development and characterization of hydrogels, particularly crosslinked polymers used in medical applications. Dr. Lowman co-founded Gelifex, Inc., which pioneered non-invasive methods for using hydrogels to repair the intervertebral disc and was acquired by Synthes in 2004. He has published over 100 journal articles and holds more than 20 issued patents. Dr. Lowman earned his chemical engineering education from the University of Virginia and Purdue University. He continues to lead innovations in biomaterials for regenerative medicine.

WIRM Advisory Board Member Zaid Matti, MD, is a musculoskeletal medicine specialist in Auckland, New Zealand, focusing on image-guided interventional procedures and orthobiologic therapies. His clinical work emphasizes the use of platelet-rich plasma (PRP) and mesenchymal stromal cells for managing complex spinal and musculoskeletal conditions. Dr. Matti serves as the Medical Director of RegenCellular and is actively involved in developing clinical protocols for biologic approaches to disease. An international lecturer, he aims to bridge the gap between interventional care, rehabilitation, and surgery. His work is centered on integrating evidence-based biologic treatments into standard musculoskeletal practice. Through his research and leadership, he continues to advance the clinical efficacy of cellular therapies in modern orthopedics.

WIRM Advisory Board Member Philippe Mavrocordatos, MD, is the CEO and Medical Director of the Swiss Pain Institute. Trained in internal medicine and anesthesiology in Switzerland and Australia, he specialized in interventional pain medicine at Royal North Shore Hospital in Sydney. Dr. Mavrocordatos has held leadership roles as Chief of Anesthesiology at the Centre Hospitalier du Nord Vaudois and Associate Physician at the University Hospital of Geneva. He served as President of the World Institute of Pain (WIP) for Switzerland from 2008 to 2015 and led the creation of TARMED for interventional pain medicine. He is an examiner for the FIPP exams and chairs the Board of Directors at the Swiss Pain Institute.

WIRM Advisory Board Member Chair of the WIRM Mexican Chapter Jesus Medina, MD, is a specialist in anesthesiology and pain management with over 10 years of clinical experience. He earned his medical degree from the Autonomous University of Guadalajara and specialized in Pain Management and Palliative Medicine at the University of Guadalajara. Dr. Medina is a Certified Interventional Pain Sonologist (CIPS) and the former President of the Sociedad Mexicana de Ultrasonido en Dolor (SMUD). As the Chair of the WIRM Mexican Chapter, he is a leading advocate for non-surgical treatments and regenerative therapies. His practice emphasizes the use of image-guided procedures to treat chronic pain, prioritizing minimally invasive options whenever possible to ensure optimal patient recovery and long-term function.

Achintya Moulick, MD, is the founder and CEO of GlobeHealer, where he advocates for healthcare quality, transparency, and cost-efficiency. A cardiothoracic surgeon with 25 years of experience, he is one of the few global experts capable of performing both adult and complex neonatal cardiac surgeries. Currently, he serves as the Executive Director and Chief of Cardiothoracic Surgery at St. Christopher’s Hospital for Children in Philadelphia. Dr. Moulick has held faculty positions at UCLA and was a founding member of the Fortis Heart Institute. He earned his medical training in India and advanced surgical training at Massachusetts General Hospital. He also holds an MBA in Healthcare and Finance from George Washington University.

Mark Edwin Murphy, MD, PhD, is an orthopedic surgeon at the Veterans Administration Hospital in San Diego with over 40 years of clinical experience. He possesses an extensive background in treating a wide range of musculoskeletal conditions affecting the spine, knees, hips, and shoulders. Dr. Murphy’s diverse professional expertise spans surgery, nonprofit organizations, medical devices, and biotechnology. He also holds a PhD, reflecting a strong foundation in molecular biology. In his practice, he emphasizes both surgical and non-surgical treatments to help patients reduce chronic pain and regain mobility. His long tenure in government administration and healthcare services makes him a respected authority in the management of complex orthopedic disorders.

Sheetal Nariani is the General Partner and Chief Financial Officer at Global Health Impact Network & Funds, a venture capital fund dedicated to democratizing investment for healthcare professionals. She has over 20 years of experience in the healthcare industry, specializing in financial management, business operations, and mergers and acquisitions. Sheetal previously held leadership roles at Novartis, where she excelled in managing complex integrations across diverse global teams. Her expertise lies in expanding operations across various geographies and fostering innovation within the medical sector. She holds multiple advanced degrees, including an MBA, which inform her strategic approach to healthcare venture capital and the growth of physician-led innovation networks.

Lakshmi Natarajan is a global executive, strategic advisor, and investor with over 20 years of experience leading growth for high-growth startups and Fortune 500 companies. She is the founder of Excelador, a management consulting firm, and serves as the Head of Venture Strategy & Investment at Xanara Advisors. Her background includes leadership roles at Oracle, Accenture, and GlaxoSmithKline, bridging corporate rigor with startup agility. Recognized as one of MSN’s Top 10 Influential Entrepreneurs in 2025, Lakshmi is a contributor to the Forbes Business Council and serves on the board of the India–US Chamber of Commerce. She is a frequent advisor to founders across the global innovation ecosystem, focusing on strategic execution and venture investment.

Aman Navani is a software engineer specializing in the intersection of cybersecurity, AI, and network security. He holds a Master of Science in Cybersecurity Management from Purdue University and a specialized certificate in Deep Learning for AI from Carnegie Mellon University. Currently, he serves as a Member of Technical Staff at Illumio, where he develops Zero Trust Segmentation solutions to prevent lateral movement by attackers within networks. His professional background includes roles as a Full Stack Software Engineer at VMO Tech and as an intern at Juniper Networks. Beyond his technical career, Aman was a dedicated competitive athlete, competing for the Tufts University Varsity Squash team at the highest collegiate level.

WIRM Chair Dr. Annu Navani serves as the Chief Medical Officer at Le Reve Regenerative & Longevity Care, where she leads advanced programs integrating regenerative and precision medicine, cellular regeneration, and age-optimization science. A board-certified specialist in Pain and Regenerative Medicine, she is recognized for pioneering innovative, evidence-based therapies that enhance healthspan and functional longevity. She is the Founder of the World Institute of Regenerative Medicine (WIRM), a global platform uniting clinicians, scientists, innovators, industry and tech leaders to advance the fields of regenerative, precision and longevity medicine. Dr. Navani also serves as the Chief Medical Officer of Boomerang Health Care, a multidisciplinary specialty network delivering interventional, surgical, and rehabilitative care.

WIRM Advisory Board Member Chair of the WIRM Brazil Chapter Victor Pacheco, MD, is a board-certified orthopedic surgeon and pain physician specializing in orthopedics and traumatology at UNICAMP. He holds the Fellow of Interventional Pain Practice (FIPP) credential from the World Institute of Pain and is board-certified by the American Academy of Regenerative Medicine. Dr. Pacheco serves as the Coordinator of Advanced Regenerative Medicine and is a board member of the Latin American Pain Society. Previously, he served as the team physician for the Santos Futebol Clube. As Chair of the WIRM Brazil Chapter, he is a leading authority on interventional pain and regenerative treatments. He remains dedicated to advancing orthopedic science and clinical excellence within the international medical community.

WIRM Advisory Board Member Xiang Qian, MD, PhD, is a Pain Management Physician and Clinical Professor at Stanford University, where he serves as the inaugural Stanford Medicine Endowed Director. He specializes in novel therapies for chronic pain conditions, including migraine, trigeminal neuralgia, and cancer pain. At Stanford, Dr. Qian leads the CT-guided interventional pain program and co-directs the Stanford Wearable Electronics Initiative (eWEAR), developing implantable nerve stimulators powered by wireless energy. He has served as Medical Director of Stanford International Medical Services (IMS) since 2016. Dr. Qian also founded the Chinese American Physicians’ Society, which has over 800 members. He is recognized globally for his leadership in clinical innovation and international medical collaboration.

WIRM Advisory Board Member Chair of the WIRM Scandinavia & Central/Eastern Europe Chapter Robert Rapcan, MD, is a consultant anesthesiologist and pain medicine specialist who currently works at Norrlands University Hospital in Sweden and the EuroPainClinics network. He performs a wide range of mini-invasive spine procedures, including epiduroscopies and advanced endoscopic discectomies. In collaboration with University Hospital Bratislava, he provides complex neuromodulation care for chronic pain and headaches. Dr. Rapcan also teaches endoscopic procedures for MaxMore in Germany and neuromodulation for Medtronic in the USA. As Chair of the WIRM Scandinavia & Central/Eastern Europe Chapter, he leads an independent healthcare network recognized for achieving high standards of innovation and efficiency in interventional pain care.

WIRM Advisory Board Member Ricardo Ruiz-Lopez, MD, is a neurosurgeon and the President and Director of Clínica Vértebra in Barcelona and Madrid. He is the founder and past President of the World Institute of Pain (WIP) and the European Federation of IASP (EFIC). Dr. Ruiz-Lopez also founded the Spanish Pain Society and the International Spine Society World Federation of Minimally Invasive Spine Surgery (WFMISS). His extensive academic work includes several books on interventional spine surgery and numerous journal publications on regenerative medicine. He serves on multiple editorial boards for journals in pain surgery and minimally invasive spine surgery. An international lecturer, he remains a cornerstone of the global pain surgery community, shaping educational standards for decades.

WIRM Advisory Board Member Michael Schatman, PhD, is a clinical psychologist with 40 years of experience in multidisciplinary chronic pain management. He serves on the faculties of the NYU Grossman School of Medicine in both the Department of Anesthesiology and the Division of Medical Ethics. Dr. Schatman is the long-standing Editor-in-Chief of the Journal of Pain Research and has authored over 275 publications. He is also a co-director of the Harvard/Mass General Interdisciplinary Pain and Headache Rounds. His research focuses on neuromodulation outcomes and ethical issues in chronic pain care. Dr. Schatman has chaired the ethics committees for the American Pain Society and the American Academy of Pain Medicine, advocating for multidisciplinary program development.

Trusha Shah, MD, is a board-certified anesthesiologist and specialist in interventional pain management and longevity medicine. A graduate of the Weill Cornell Pain Medicine Fellowship, she is the founder and medical director of Shah Spine & Pain and Shah Wellness & Aesthetics. Dr. Shah utilizes an integrative approach that bridges regenerative medicine with the science of longevity, offering advanced therapies such as peptide infusions, bioidentical hormone therapy, and PRP. Her clinical focus is on addressing the root causes of aging and chronic pain to restore patient function and balance. A frequent speaker and thought leader, she is dedicated to creating personalized treatment pathways that combine modern medical science with artistry and compassion to redefine aging well.

Anil K. Sharma, MD, is the Founder and President of Spine & Pain Centers of New Jersey and New York and a nationally recognized leader in interventional pain management. A Valedictorian graduate of MGM Medical College, he completed his fellowship at the Cleveland Clinic, where he was honored as the Best Graduating Fellow. Over a 30-year career, Dr. Sharma has performed more than 80,000 spinal procedures, specializing in minimally invasive techniques and complex chronic pain diagnosis. He has been named a “Top Doctor” for 14 consecutive years. An influential educator and Wharton alumnus, Dr. Sharma is also a strategic entrepreneur who founded Third Eye Capital Management. Through the Sharma Family Foundation, he supports global healthcare, education, and essential resources like clean water in developing nations.

WIRM Advisory Board Member Ashish Shetty, MD, is a Consultant Lead in Pain Medicine at University College London Hospitals and an Associate Professor at UCL. He received his training at Cambridge University Hospitals and completed a clinical fellowship in pain management at Guy’s & St Thomas’ Hospital in London. Dr. Shetty also serves as a consultant at the Harley Street Clinic and Cleveland Clinic. His special clinical interests include chronic pain management through neuromodulation and spinal cord stimulators, with specific expertise in pelvic pain, CRPS, and sports medicine. As a respected educator and researcher, he is involved in advancing interventional techniques within the UK healthcare system. He remains a key figure in modern pain management and sports-related injury recovery.

Prof. Paul J. Simmons, PhD, is the Chief Scientific Advisor to Mesoblast Ltd., having previously served as the company’s Head of Research and Product Development for 12 years. His pioneering work on the isolation of mesenchymal stromal cells (MSCs) formed the technical foundation for the company’s global cellular medicine platform. Over a career spanning more than 30 years, Dr. Simmons has held prestigious leadership roles, including Director of the Centre for Stem Cell Research at the University of Texas Health Science Center at Houston and Program Head at the Peter MacCallum Cancer Centre. A global authority in hematopoiesis and stem cell biology, he served as President of the International Society for Stem Cell Research (ISSCR). With over 25,000 citations, he remains dedicated to translating biological discoveries into commercialized clinical therapies.

Kamal Singh is a Senior Vice President at WestBridge Capital, where he focuses on investments across the technology and healthcare sectors. He is particularly interested in companies that leverage AI and data-driven innovation to improve clinical workflows and patient outcomes. Prior to joining WestBridge, he served as a tech-focused investment banking associate at Evercore Partners, covering SaaS and cybersecurity verticals. His professional experience also includes roles at Accenture and The Chesapeake Group, a mid-market M&A advisory firm focused on the US-India corridor. Mr. Singh holds a bachelor’s degree from the Indian Institute of Technology, Kharagpur, and an MBA from Columbia Business School. He uses his financial and technical background to identify transformative healthcare solutions.

H. Thomas Temple, MD, is an orthopedic oncologist and surgeon specializing in musculoskeletal oncology and regenerative medicine. He holds several leadership titles at Nova Southeastern University, including Senior Vice President of Translational Research and Executive Associate Dean of Research. Dr. Temple earned his medical degree from Jefferson Medical College and received advanced training at Walter Reed Army Medical Center, Massachusetts General Hospital, and Boston Children’s Hospital. He has authored over 200 scientific articles and serves as an Assistant Editor for Foot and Ankle International. A member of the American Academy of Orthopedic Surgeons, his work focuses on mentoring future surgeons and advancing the clinical application of tissue banking and biological treatments for tumors.

Kat Toups, MD, is a board-certified psychiatrist with over 30 years of experience in geriatric psychiatry and dementia research. For 13 years, she directed a clinical trials research center and served as the principal investigator for over 100 trials, including 20 focused on Alzheimer’s disease and mild cognitive impairment. Dr. Toups is a pioneer in multimodal precision medicine approaches designed to reverse cognitive decline. Her collaborative research with Dr. Dale Bredesen has demonstrated a success rate exceeding 90% in reversing early Alzheimer’s in her most recent randomized clinical trial. She is dedicated to advancing functional medicine strategies that target the prevention and reversal of neurodegenerative disorders, offering hope to patients and families worldwide.

Michael P. Webb is a presenter for Legally Mine, INC., and a seasoned entrepreneur based in Leeds, Utah. He built and managed a successful company for 21 years before selling the business to focus on consulting and training for entrepreneurs. With 14 years of experience in small business training, Michael possesses a deep understanding of the operational and legal challenges faced by independent practices. In his current role, he teaches healthcare professionals how to eliminate the threat of lawsuits, protect their medical licenses, and maximize tax savings through strategic business structures. His education includes general studies at Brigham Young University. He remains a leading educator on asset protection for the medical community.

WIRM Advisory Board Member David C. Yeomans, PhD, is a professor at the Stanford University School of Medicine, where he has primarily focused on elucidating mechanisms of chronic pain and developing novel means of treatment.  More recently though, and based on recent discoveries, he has focused on designing drugs that can manipulate multiple transcription factors simultaneously for the regenerative treatment of degenerative disorders, the first target disease being Huntington’s Disease.  Dr. Yeomans is an author of many ground-breaking papers and patents and has received several awards and visiting professorships at numerous universities for his work.  He has also been active in industry, having founded three biotechnology companies and served on advisory boards of several biotechnology, pharmaceutical, and medical device companies an as an advisor to several intellectual property law firms and investment groups.

Alan Young, MD, is a physician executive and AI strategist who bridges the gap between patient care and pragmatic technology roadmaps. He has served as Chief Medical Officer at GYANT and Safe Health and as Head of Clinical Partnerships at Kela Health, where he led the integration of conversational platforms and predictive models into clinical workflows. Dr. Young’s experience includes tenure at major consulting firms such as McKinsey and Deloitte, focusing on outcomes-oriented governance and safety standards. A mentor for the Cedars-Sinai Accelerator and Techstars Healthcare, he champions co-design between technologists and clinicians. He holds an MD/MBA from the University of Southern California and is dedicated to advancing ethical, clinically sound artificial intelligence